NCT05803070Status unknown
Topical Cetirizine in Treatment of Localized Alopecia Areata
Topical Cetirizine Versus Topical Betamethasone in Treatment of Localized Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- No phase declared
- Sponsor
- Assiut University
- Participants (registry)
- 59
- Start
- September 2023
- Primary completion
- September 2024
- Study completion
- October 2024
- Last registry update
- April 2023
- Countries
- —
Conditions studied: Alopecia Areata
Interventions: Topical Cetirizine 1 %, Topical betamethasone valerate 0.1%
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.